CN110934928A - Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina - Google Patents

Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina Download PDF

Info

Publication number
CN110934928A
CN110934928A CN201911402791.XA CN201911402791A CN110934928A CN 110934928 A CN110934928 A CN 110934928A CN 201911402791 A CN201911402791 A CN 201911402791A CN 110934928 A CN110934928 A CN 110934928A
Authority
CN
China
Prior art keywords
parts
preparation
houjiling
radix
herpangina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201911402791.XA
Other languages
Chinese (zh)
Inventor
黄炜忠
叶耀良
滕云霞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong Luofushan Sinopharm Co Ltd
Original Assignee
Guangdong Luofushan Sinopharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong Luofushan Sinopharm Co Ltd filed Critical Guangdong Luofushan Sinopharm Co Ltd
Priority to CN201911402791.XA priority Critical patent/CN110934928A/en
Publication of CN110934928A publication Critical patent/CN110934928A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37Digestive system
    • A61K35/413Gall bladder; Bile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/618Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/19Acanthaceae (Acanthus family)
    • A61K36/195Strobilanthes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/34Campanulaceae (Bellflower family)
    • A61K36/346Platycodon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/42Cucurbitaceae (Cucumber family)
    • A61K36/428Trichosanthes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483Gleditsia (locust)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489Sophora, e.g. necklacepod or mamani
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/63Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634Forsythia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/83Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/55Liquid-liquid separation; Phase separation

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight: the preparation is prepared from 0.5-2 parts of artificial bezoar, 15-18 parts of platycodon grandiflorum, 1-4 parts of fructus gleditsiae, 15-18 parts of rhizoma isatidis, 0.5-1.5 parts of borneol, 25-30 parts of subprostrate sophora, 10-15 parts of myrobalan, 1-4 parts of radix trichosanthis, 11-15 parts of fructus forsythiae, 13-19 parts of radix achyranthis bidentatae from Guangdong, 0.5-2 parts of pearl layer powder and 25-32 parts of Indian stringbush root.

Description

Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina
Technical Field
The invention relates to the technical field of new application of Chinese patent medicines, in particular to application of a Houjiling preparation in preparing a medicine for treating pharyngitis and herpangina.
Background
Pharyngitis refers to pharyngeal diseases with red, swollen and painful pharynx, or dry throat, foreign body sensation, pharynx itch and discomfort caused by invasion of exogenous pathogenic factors, obstruction of lung system, pathogenic factors in pharynx, or viscera deficiency, malnutrition of throat, or deficiency fire burning, or symptoms such as fever, pain, cough, etc.; the herpangina is acute infectious pharyngitis which is caused by enterovirus and is characterized by acute fever and herpangina herpes ulcer, can be directly transmitted through intestinal tracts or respiratory tracts and can also be indirectly transmitted through polluted hands, food, clothes, appliances and the like, has strong infectivity and quick transmission, is diffused or popularized all over the world, is a high-incidence season in summer and autumn, and is clinically mainly manifested by fever, angina, small herpes of the mucous membrane of the herpangina and superficial ulcer; at present, most of the medicines have the effects of promoting blood circulation to remove blood stasis, detoxifying and relieving sore throat, and resolving dampness and reducing fever, but the medicines have poor effects, long treatment course and easy recurrence.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides the application of the Houjiling preparation in preparing the medicine for treating pharyngitis and herpangina, the Houjiling preparation has the effects of clearing heat, relieving sore throat, astringing sores and relieving pain, has obvious curative effect, quick response and no toxic or side effect, and can solve the problems of pharyngitis, herpangina and the like caused by excessive internal heat.
In order to solve the technical problems, the invention is realized by the following technical scheme:
the traditional Chinese medicine components can be replaced by traditional Chinese medicines with the same or similar efficacies, and the traditional Chinese medicines can be processed according to the national traditional Chinese medicine processing standard.
The invention discloses an application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight: 0.5-2 parts of artificial bezoar, 15-18 parts of platycodon grandiflorum, 1-4 parts of fructus gleditsiae, 15-18 parts of rhizoma isatidis, 0.5-1.5 parts of borneol, 25-30 parts of subprostrate sophora, 10-15 parts of myrobalan, 1-4 parts of radix trichosanthis, 11-15 parts of fructus forsythiae, 13-19 parts of radix achyranthis bidentatae, 0.5-2 parts of pearl layer powder and 25-32 parts of wikstroemia indica.
Further, the Houjiling preparation comprises the following components in parts by weight: 0.9-1.8 parts of artificial bezoar, 15.5-17.5 parts of balloonflower root, 1.5-3.5 parts of fructus gleditsiae, 15.5-17.5 parts of rhizoma et radix baphicacanthis cusiae, 0.7-1.3 parts of borneol, 26-29 parts of radix sophorae tonkinensis, 12-14 parts of myrobalan, 1.5-3.5 parts of radix trichosanthis, 12-14 parts of fructus forsythiae, 14.5-17.5 parts of radix achyranthis bidentatae, 0.9-1.8 parts of pearl layer powder and 27-31 parts of wikstroemia indica.
Further, the Houjiling preparation comprises the following components in parts by weight: 0.5 part of artificial bezoar, 15.5 parts of platycodon grandiflorum, 1.5 parts of fructus gleditsiae, 15.5 parts of rhizoma isatidis, 0.7 part of borneol, 26 parts of subprostrate sophora, 12 parts of myrobalan, 2 parts of trichosanthes root, 12 parts of fructus forsythiae, 14.5 parts of radix achyranthis bidentatae, 0.9 part of pearl layer powder and 27 parts of wikstroemia indica.
Further, the Houjiling preparation comprises the following components in parts by weight: 2 parts of artificial bezoar, 17.5 parts of platycodon grandiflorum, 3.5 parts of fructus gleditsiae, 17.5 parts of rhizoma isatidis, 1.3 parts of borneol, 29 parts of subprostrate sophora, 14 parts of myrobalan, 4 parts of trichosanthes root, 14 parts of fructus forsythiae, 17.5 parts of radix achyranthis bidentatae, 1.8 parts of pearl layer powder and 31 parts of wikstroemia indica.
Further, the Houjiling preparation comprises the following components in parts by weight: 1.0 part of artificial bezoar, 16.5 parts of platycodon grandiflorum, 2.75 parts of fructus gleditsiae, 16.5 parts of radix isatidis, 1.0 part of borneol, 27.5 parts of subprostrate sophora, 13.8 parts of myrobalan, 2.75 parts of radix trichosanthis, 13.8 parts of fructus forsythiae, 16.5 parts of radix achyranthis bidentatae from Guangdong, 1.0 part of pearl layer powder and 27.5 parts of Indian stringbush root.
Further, the medicine is an oral administration preparation.
Furthermore, the dosage form of the medicine is capsule, soft capsule, tablet, dispersible tablet, orally disintegrating tablet, effervescent tablet or dripping pill.
Further, the Houjiling preparation is prepared by adopting the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice, 1-3 hr for the first time and 2-3 hr for the second time, filtering, mixing filtrates, concentrating to obtain soft extract with relative density of 1.20-1.30 at 45-55 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, collecting supernatant, washing residue with 75% ethanol, mixing the washing solution and supernatant, recovering ethanol, and concentrating to obtain soft extract with relative density of 1.25-1.35 at 45-55 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) and (3) uniformly mixing the fine powder in the step (2) and the fine powder in the step (5), and preparing a clinically acceptable oral administration preparation form directly or by adding pharmaceutically acceptable auxiliary materials through a conventional process.
The inventor of the application discovers through a large amount of researches that the oral administration preparation prepared by the Houjiling preparation can effectively treat pharyngitis and herpangina and provides a new selection and treatment approach for patients, in particular, the artificial bezoar, the south isatis root, the subprostrate sophora root, the trichosanthes root, the forsythia, the pearl layer powder and the Indian stringbush root added in the formula are mutually cooperated, so that each traditional Chinese medicine can play the efficacies of clearing away heat and toxic materials, relieving sore throat and dissipating stagnation, and reducing swelling and allaying fever to the maximum extent, and the borneol, the pig soap and the radix achyranthis bidentatae in the formula are mutually cooperated, so that the efficacies of activating blood and removing stasis, healing sore and promoting granulation, reducing swelling and relieving pain and the like are well realized, the pain of patients is greatly relieved, the illness state can be timely controlled, the effect is fast, the Houjiling preparation disclosed by the invention can effectively improve the organism function, improve the immunity, the recurrence is avoided after the cure, and the medicine, has strong pertinence, convenient taking and good absorption effect, and really achieves the aim of treating both principal and secondary aspect of disease.
The Houjiling preparation has obvious significance for clinical treatment of pharyngitis and herpangina, and has no obvious adverse reaction while effectively treating.
The Houjiling preparation has scientific compatibility, synergistic effect of the components, obvious curative effect, quick response and no toxic or side effect, and long-term clinical practice shows that the Houjiling preparation has the effects of obviously clearing heat and relieving sore throat, healing sore and relieving pain, is beneficial to keeping the internal functions of a human body in a good state, fundamentally eliminates the source of disease, has good curative effect on treating pharyngitis and herpangina, and is suitable for clinical application.
Typical cases are:
the medicine is taken for treatment, the body temperature is reduced after 1 day of taking, the symptoms are obviously relieved, after the medicine is continuously taken for 4 days, the body temperature of a patient is recovered to be normal, the pharynx and related parts are recovered to be normal, and the treatment effect is obvious.
In Sunzhi, male, 59 years old, the patient often has dry and painful throat, burning sensation, cough without phlegm, frequent drinking, but not much drinking, and when diagnosed: the throat congestion is dark red, the mucous membrane is dry, the tongue is red, the tongue coating is thin, the pulse is thin and rapid, and after the medicament prepared by the throat disease preparation of the invention is taken for 5 days, the pain and burning sensation are relieved, and the drinking water is normal; after the medicine is continuously taken for 10 days, the choking cough disappears, and no abnormality exists in the pharynx; the medicine is continuously taken for 3 days for curing.
Detailed Description
To facilitate understanding of the invention by those skilled in the art, the invention is further described below with reference to specific examples, which are not intended to limit the scope of the invention.
Example 1
The embodiment provides application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight:
0.5 part of artificial bezoar, 15 parts of platycodon grandiflorum, 1 part of fructus gleditsiae, 15 parts of rhizoma isatidis, 0.5 part of borneol, 25 parts of subprostrate sophora, 10 parts of myrobalan, 2 parts of radix trichosanthis, 11 parts of fructus forsythiae, 13 parts of radix achyranthis bidentatae, 0.5 part of pearl layer powder and 25 parts of wikstroemia indica.
The preparation form of the Houjiling preparation is capsules, and further the Houjiling capsules are prepared by adopting the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice (1 hr for the first time and 2 hr for the second time), filtering, mixing filtrates, concentrating into soft extract with relative density of 1.20 at 45 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, collecting supernatant, washing the residue with 75% ethanol, mixing the washing solution and the supernatant, recovering ethanol, and concentrating into soft extract with relative density of 1.25 at 45 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) mixing the fine powder of step (2) and the fine powder of step (5), adding starch, mixing, and directly or granulating and encapsulating;
example 2
The embodiment provides application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight:
2 parts of artificial bezoar, 18 parts of platycodon grandiflorum, 4 parts of fructus gleditsiae, 18 parts of radix isatidis, 1.5 parts of borneol, 30 parts of subprostrate sophora, 15 parts of myrobalan, 4 parts of radix trichosanthis, 15 parts of fructus forsythiae, 19 parts of radix achyranthis bidentatae, 2 parts of pearl layer powder and 32 parts of wikstroemia indica.
The preparation form of the Houjiling preparation is a soft capsule, and further the Houjiling soft capsule is prepared by adopting the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice, 3 hr for the first time and 3 hr for the second time, filtering, mixing filtrates, concentrating into soft extract with relative density of 1.30 at 55 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, sucking supernatant, washing the residue with 75% ethanol, mixing the washing solution and supernatant, recovering ethanol, and concentrating into soft extract with relative density of 1.35 at 55 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) and (3) uniformly mixing the fine powder obtained in the step (2) and the fine powder obtained in the step (5), and sieving to prepare the content of the soft capsule, wherein the capsule material ratio is gelatin: preparing the glycerol and the water with the mass ratio of 1:0.15:0.85 into a soft capsule by a pressing method;
example 3
The embodiment provides application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight:
0.9 part of artificial bezoar, 15.5 parts of platycodon grandiflorum, 1.5 parts of fructus gleditsiae, 15.5 parts of rhizoma isatidis, 0.7 part of borneol, 26 parts of subprostrate sophora, 12 parts of myrobalan, 1.5 parts of radix trichosanthis, 12 parts of fructus forsythiae, 14.5 parts of radix achyranthis bidentatae, 0.9 part of pearl layer powder and 27 parts of wikstroemia indica.
The dosage form of the Houjiling preparation is effervescent tablets, and further the Houjiling effervescent tablets are prepared by adopting the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice, 1.5 hr for the first time and 2.5 hr for the second time, filtering, mixing filtrates, concentrating into soft extract with relative density of 1.24 at 50 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, sucking supernatant, washing residue with 75% ethanol, mixing the washing solution and supernatant, recovering ethanol, and concentrating into soft extract with relative density of 1.28 at 50 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) and (3) uniformly mixing the fine powder obtained in the step (2) and the fine powder obtained in the step (5), uniformly mixing the fine powder with starch, sodium carboxymethyl starch, sodium bicarbonate and citric acid with equivalent weight, and directly tabletting to obtain the tablet.
Example 4
The embodiment provides application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight:
1.8 parts of artificial bezoar, 17.5 parts of platycodon grandiflorum, 3.5 parts of fructus gleditsiae, 17.5 parts of rhizoma isatidis, 1.3 parts of borneol, 29 parts of radix sophorae tonkinensis, 14 parts of myrobalan, 3.5 parts of radix trichosanthis, 14 parts of fructus forsythiae, 17.5 parts of radix achyranthis bidentatae, 1.8 parts of pearl layer powder and 31 parts of wikstroemia indica.
The preparation form of the Houjiling preparation is orally disintegrating tablets, and further the Houjiling orally disintegrating tablets are prepared by adopting the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice, 2 hr for the first time and 2.5 hr for the second time, filtering, mixing filtrates, concentrating into soft extract with relative density of 1.28 at 54 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, sucking supernatant, washing the residue with 75% ethanol, mixing the washing solution and supernatant, recovering ethanol, and concentrating into soft extract with relative density of 1.33 at 54 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) and (3) uniformly mixing the fine powder in the step (2) and the fine powder in the step (5), granulating with sodium carboxymethyl starch by using 75% ethanol, drying, adding polyvinylpyrrolidone and magnesium stearate, uniformly mixing, and pressing into tablets.
Example 5
The embodiment provides application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight:
0.5 part of artificial bezoar, 15.5 parts of platycodon grandiflorum, 1.5 parts of fructus gleditsiae, 15.5 parts of rhizoma isatidis, 0.7 part of borneol, 26 parts of subprostrate sophora, 12 parts of myrobalan, 2 parts of trichosanthes root, 12 parts of fructus forsythiae, 14.5 parts of radix achyranthis bidentatae, 0.9 part of pearl layer powder and 27 parts of wikstroemia indica.
The dosage form of the Houjiling preparation is a dripping pill, and further the Houjiling dripping pill is prepared by adopting the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice (2 hr for the first time and 2.5 hr for the second time), filtering, mixing filtrates, concentrating into soft extract with relative density of 1.24 at 52 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, sucking supernatant, washing the residue with 75% ethanol, mixing the washing solution and supernatant, recovering ethanol, and concentrating into soft extract with relative density of 1.32 at 52 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) mixing the fine powder of step (2) and the fine powder of step (5), adding the fine powder into molten polyethylene glycol 4000, stirring, keeping the temperature at 45 deg.C, pouring into a dripping pill device, dripping into liquid paraffin of 6 deg.C at a dripping speed of 30d/min, and making into dripping pill.
Example 6
The embodiment provides application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight:
2 parts of artificial bezoar, 17.5 parts of platycodon grandiflorum, 3.5 parts of fructus gleditsiae, 17.5 parts of rhizoma isatidis, 1.3 parts of borneol, 29 parts of subprostrate sophora, 14 parts of myrobalan, 4 parts of trichosanthes root, 14 parts of fructus forsythiae, 17.5 parts of radix achyranthis bidentatae, 1.8 parts of pearl layer powder and 31 parts of wikstroemia indica.
The dosage form of the houjiling preparation is a dispersible tablet, and further, the houjiling dispersible tablet is prepared by adopting the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice, 2 hr for the first time and 2.5 hr for the second time, filtering, mixing filtrates, concentrating into soft extract with relative density of 1.28 at 54 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, sucking supernatant, washing the residue with 75% ethanol, mixing the washing solution and supernatant, recovering ethanol, and concentrating into soft extract with relative density of 1.33 at 54 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) and (3) uniformly mixing the fine powder obtained in the step (2) and the fine powder obtained in the step (5), adding cross-linked sodium carboxymethyl starch, low-substituted hydroxypropyl cellulose and microcrystalline cellulose, uniformly mixing, preparing into granules, adding starch and magnesium stearate, pressing into dispersible tablets, and coating films.
Example 7
The embodiment provides application of a houjiling preparation in preparing a medicament for treating pharyngitis and herpangina, wherein the houjiling preparation comprises the following components in parts by weight:
1.0 part of artificial bezoar, 16.5 parts of platycodon grandiflorum, 2.75 parts of fructus gleditsiae, 16.5 parts of radix isatidis, 1.0 part of borneol, 27.5 parts of subprostrate sophora, 13.8 parts of myrobalan, 2.75 parts of radix trichosanthis, 13.8 parts of fructus forsythiae, 16.5 parts of radix achyranthis bidentatae from Guangdong, 1.0 part of pearl layer powder and 27.5 parts of Indian stringbush root.
The preparation form of the Houjiling preparation is tablets, and further the Houjiling tablets are prepared by adopting the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice, 2 hr for the first time and 2.5 hr for the second time, filtering, mixing filtrates, concentrating into soft extract with relative density of 1.25 at 50 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, sucking supernatant, washing the residue with 75% ethanol, mixing the washing solution and supernatant, recovering ethanol, and concentrating into soft extract with relative density of 1.30 at 50 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) and (3) uniformly mixing the fine powder in the step (2) and the fine powder in the step (5), sieving, adding starch and dextrin to prepare granules, drying the granules, adding magnesium stearate, pressing the granules into tablets, and coating sugar coat or film coat.
Comparative example 1
The comparative example is different from example 7 only in the raw material components, and the raw material components of the comparative example do not include platycodon grandiflorum, subprostrate sophora root, and radix isatidis, and the others are the same as example 7.
The comparison of the sore throat relieving and cough stopping effects of the Houjiling preparations obtained in examples 1-5 and comparative example 1 is as follows.
1. Test subjects: ICR mice.
2. The test process comprises the following steps: taking 70 healthy ICR mice, dividing the mice into 7 groups, and 10 mice in each group; one group is blank group, and the others are experimental group; the Houjiling preparation obtained in examples 1-5 and comparative example 1 was used in an aerosol inhalation manner in the experimental group, and the administration dose was 8 g/kg; the blank group is administered twice a day for five days by using purified water with the same amount in an atomization inhalation manner; 1 hour after the last administration, each group of mice was stimulated with ammonia water, and the cough latency and the number of coughs within 3 minutes were recorded for each experimental group of mice, and the results were recorded.
3. Test results
Figure DEST_PATH_IMAGE001
As can be seen from Table 1, the mice of the groups of examples 1-5 had significantly longer cough latency times after ammonia challenge than the groups of comparative example 1 and the blank; the cough frequency of the mice in the groups of examples 1 to 5 in 3 minutes is obviously less than that of the mice in the group of comparative example 1 and the blank group, which shows that the Houjiling preparation obtained in the groups of examples 1 to 5 can obviously prolong the incubation period of cough of the mice induced by ammonia water and reduce the cough frequency, and further shows that the Houjiling preparation has obvious effects of relieving sore throat and relieving cough; it is further shown that the group of comparative example 1 has the effects of relieving sore throat and cough, but cannot exert the maximum curative effect, and the curative effect is not ideal.
The beneficial effects of the Houjiling preparation of the present invention are further illustrated by clinical cases.
Selecting 180 cases of patients with pharyngitis and herpangina as test objects, randomly dividing the test objects into 6 groups, wherein each group contains 30 patients, and 1-5 test groups respectively adopt the Houjiling effervescent tablet, the Houjiling orally disintegrating tablet, the Houjiling soft drop pill, the Houjiling dispersible tablet and the Houjiling tablet which are prepared in the embodiments 3-7, wherein the Houjiling drop pill is taken with warm water 3 times a day, 10-15 pills each time; the rest of the tablets are taken 3 times a day, 4 tablets each time, with warm water, 1 course of treatment for 14 days after continuous administration, and 4 courses of treatment for 14 days after double-diagnosis. The control group is orally administered with QINGKAILING granule 3-6g (1-2 bags) once, three times per day, 14 days as 1 course of treatment, and observation time as 4 courses of treatment.
The standard of curative effect is drawn up according to the standard of curative effect of diagnosis of traditional Chinese medicine syndrome by the State administration of traditional Chinese medicine:
1. and (3) curing: clinical symptoms disappear, and no recurrence occurs after half a year of follow-up visit;
2. the effect is shown: the clinical symptoms and physical signs are obviously relieved;
3. the method has the following advantages: the clinical symptoms and physical signs are reduced, the attack frequency is reduced, and the attack duration is shorter;
4. and (4) invalidation: those with no improvement or aggravation of symptoms and signs.
The efficacy of the test groups 1-5 was compared with that of the control group 1, and is shown in Table 2.
Figure 733166DEST_PATH_IMAGE002
It can be seen from table 2 that the effective rate of the test group 1-5 is more than 85%, and is greatly superior to the control group 1 when compared with the control group 1, thus the throat disease preparation of the invention has obvious curative effect on the pharyngitis and the herpangina, and has good popularization value.
The above-mentioned embodiments only express the embodiments of the present invention, and the description is more specific and detailed, but not understood as the limitation of the patent scope of the present invention, but all the technical solutions obtained by using the equivalent substitution or the equivalent transformation should fall within the protection scope of the present invention.

Claims (8)

1. The application of the Houjiling preparation in preparing the medicine for treating pharyngitis and herpangina is characterized in that the Houjiling preparation comprises the following components in parts by weight: 0.5-2 parts of artificial bezoar, 15-18 parts of platycodon grandiflorum, 1-4 parts of fructus gleditsiae, 15-18 parts of rhizoma isatidis, 0.5-1.5 parts of borneol, 25-30 parts of subprostrate sophora, 10-15 parts of myrobalan, 1-4 parts of radix trichosanthis, 11-15 parts of fructus forsythiae, 13-19 parts of radix achyranthis bidentatae, 0.5-2 parts of pearl layer powder and 25-32 parts of wikstroemia indica.
2. The use of the Houjiling preparation as claimed in claim 1 for preparing a medicament for treating pharyngitis and herpangina, wherein the Houjiling preparation comprises the following components in parts by weight: 0.9-1.8 parts of artificial bezoar, 15.5-17.5 parts of balloonflower root, 1.5-3.5 parts of fructus gleditsiae, 15.5-17.5 parts of rhizoma et radix baphicacanthis cusiae, 0.7-1.3 parts of borneol, 26-29 parts of radix sophorae tonkinensis, 12-14 parts of myrobalan, 1.5-3.5 parts of radix trichosanthis, 12-14 parts of fructus forsythiae, 14.5-17.5 parts of radix achyranthis bidentatae, 0.9-1.8 parts of pearl layer powder and 27-31 parts of wikstroemia indica.
3. The use of the Houjiling preparation as claimed in claim 1 for preparing a medicament for treating pharyngitis and herpangina, wherein the Houjiling preparation comprises the following components in parts by weight: 0.5 part of artificial bezoar, 15.5 parts of platycodon grandiflorum, 1.5 parts of fructus gleditsiae, 15.5 parts of rhizoma isatidis, 0.7 part of borneol, 26 parts of subprostrate sophora, 12 parts of myrobalan, 2 parts of trichosanthes root, 12 parts of fructus forsythiae, 14.5 parts of radix achyranthis bidentatae, 0.9 part of pearl layer powder and 27 parts of wikstroemia indica.
4. The use of the Houjiling preparation as claimed in claim 1 for preparing a medicament for treating pharyngitis and herpangina, wherein the Houjiling preparation comprises the following components in parts by weight: 2 parts of artificial bezoar, 17.5 parts of platycodon grandiflorum, 3.5 parts of fructus gleditsiae, 17.5 parts of rhizoma isatidis, 1.3 parts of borneol, 29 parts of subprostrate sophora, 14 parts of myrobalan, 4 parts of trichosanthes root, 14 parts of fructus forsythiae, 17.5 parts of radix achyranthis bidentatae, 1.8 parts of pearl layer powder and 31 parts of wikstroemia indica.
5. The use of the Houjiling preparation as claimed in claim 1 for preparing a medicament for treating pharyngitis and herpangina, wherein the Houjiling preparation comprises the following components in parts by weight: 1.0 part of artificial bezoar, 16.5 parts of platycodon grandiflorum, 2.75 parts of fructus gleditsiae, 16.5 parts of radix isatidis, 1.0 part of borneol, 27.5 parts of subprostrate sophora, 13.8 parts of myrobalan, 2.75 parts of radix trichosanthis, 13.8 parts of fructus forsythiae, 16.5 parts of radix achyranthis bidentatae from Guangdong, 1.0 part of pearl layer powder and 27.5 parts of Indian stringbush root.
6. The use of the Houjiling preparation according to claim 1 for the preparation of a medicament for treating pharyngitis and herpangina, wherein said medicament is an orally administrable preparation.
7. The use of the Houjiling preparation as claimed in claim 6, wherein the medicament is in the form of capsule, soft capsule, tablet, dispersible tablet, orally disintegrating tablet, effervescent tablet or drop pill.
8. The use of the Houjiling preparation as claimed in claim 1 for the preparation of a medicament for treating pharyngitis and herpangina, wherein the Houjiling preparation is prepared by the following method:
(1) weighing the components according to the using amount of the components;
(2) grinding Borneolum Syntheticum, and mixing with artificial calculus bovis and Margarita powder to obtain fine powder;
(3) pulverizing fructus Chebulae into fine powder;
(4) decocting radix Platycodi, fructus Gleditsiae Abnormalis, radix Isatidis, radix Sophorae Tonkinensis, Trichosanthis radix, fructus forsythiae, radix Stephaniae Japonicae and Indian Stringbush in water twice, 1-3 hr for the first time and 2-3 hr for the second time, filtering, mixing filtrates, concentrating to obtain soft extract with relative density of 1.20-1.30 at 45-55 deg.C, cooling, adding 2 times of ethanol, stirring, standing overnight, collecting supernatant, washing residue with 75% ethanol, mixing the washing solution and supernatant, recovering ethanol, and concentrating to obtain soft extract with relative density of 1.25-1.35 at 45-55 deg.C;
(5) adding the fine powder in the step (3) into the thick paste in the step (4), uniformly mixing, drying and crushing into fine powder;
(6) and (3) uniformly mixing the fine powder in the step (2) and the fine powder in the step (5), and preparing a clinically acceptable oral administration preparation form directly or by adding pharmaceutically acceptable auxiliary materials through a conventional process.
CN201911402791.XA 2019-12-31 2019-12-31 Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina Withdrawn CN110934928A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911402791.XA CN110934928A (en) 2019-12-31 2019-12-31 Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911402791.XA CN110934928A (en) 2019-12-31 2019-12-31 Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina

Publications (1)

Publication Number Publication Date
CN110934928A true CN110934928A (en) 2020-03-31

Family

ID=69912710

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911402791.XA Withdrawn CN110934928A (en) 2019-12-31 2019-12-31 Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina

Country Status (1)

Country Link
CN (1) CN110934928A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1739677A (en) * 2005-08-25 2006-03-01 叶耀良 Houjiling prepn for treating throat diseases and its use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1739677A (en) * 2005-08-25 2006-03-01 叶耀良 Houjiling prepn for treating throat diseases and its use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
梁剑波: "喉疾灵胶囊治疗咽喉等疾患的临床观察" *
谢水兴;: "喉疾灵效应" *

Similar Documents

Publication Publication Date Title
RU2519643C2 (en) Pharmaceutical composition containing ephedrae herba for treating bronchitis, and method for preparing it
CN102309716B (en) Traditional Chinese medicine composition for treating morbid leucorrhea and preparation method thereof
CN101947285B (en) Buccal tablet for treating chronic pharyngitis
CN104642698A (en) Candy capable of clearing heat, relieving sore-throat and detoxifying
CN104887952B (en) Composition with yin nourishing and lung moistening effects and preparation method and application thereof
CN101683420A (en) Applications of traditional Chinese medicine composition in preparation of medicament for treating acute pharyngitis
CN103768429A (en) Traditional Chinese medicinal composition for treating acute and chronic pharyngitis and preparation method thereof
CN103301271B (en) Tibetan medicine for treating pharyngitis and preparation method thereof
CN109528868A (en) A kind of Chinese medicine composition treats aphthae in preparation, the application in the drug of carbuncle swells furunculosis
CN103735679A (en) Chinese medicine composition for diminishing inflammation and relieving sore throat and preparation method thereof
CN110934928A (en) Application of Houjiling preparation in preparation of medicine for treating pharyngitis and herpangina
CN107744554A (en) A kind of pharyngitis mouth-sucking tablet and preparation method thereof
CN113144141A (en) A Chinese medicinal composition for treating cough
CN102885929B (en) A kind ofly treat Chinese medicine preparation of bottleneck throat inflammation and preparation method thereof
CN105748899A (en) Pharmaceutical preparation for treating pharyngitis and use thereof
CN104815151A (en) Traditional Chinese medicine for treating warm-dryness lung injury type cough
CN109674854A (en) A kind of shield pharynx treasure pill and preparation method thereof
CN109663012A (en) Dispelling wind and heat, removing toxic substances relieving sore-throat Chinese medicine composition and the preparation method and application thereof
CN104225405A (en) Chinese medicinal buccal tablet for treating respiratory tract infection and preparation method
CN110946929B (en) Application of Houjiling preparation in preparing medicament for treating furunculosis
CN103610934A (en) Traditional Chinese medicine for treating pharyngitis
CN106110244A (en) Powder for relieving cough and asthma
CN101015616A (en) Chinese medicine composition for treating children pneumonia and preparing method thereof
CN1236783C (en) Herb kalimeris indica infusion preparation method
CN105056065A (en) Traditional Chinese medicine composition for treating sphagitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20200331